Summary and Concluding Remarks
Patients with DM often present with multivessel disease and complex lesions. The polymer-free technology of the Cre8™ stent makes it a good choice in patients with diabetes. Clinical studies to date have demonstrated excellent outcomes in this important patient subgroup. The live case demonstrated the advantages of the Cre8™, which include minimising time taking DAPT, an important consideration for patients who are also receiving oral anticoagulation.
The publication of this article was supported by Alvimedica.